Cargando…

Strategic investment in tuberculosis control in the Republic of Bulgaria

As Bulgaria transitions away from Global Fund grant, robust estimates of the comparative impact of the various response strategies under consideration are needed to ensure sustained effectiveness of the tuberculosis (TB) programme. We tailored an established mathematical model for TB control to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Doan, T. N., Varleva, T., Zamfirova, M., Tyufekchieva, M., Keshelava, A., Hristov, K., Yaneva, A., Gadzheva, B., Zhang, S., Irbe, S., Ragonnet, R., McBryde, E. S., Trauer, J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873158/
https://www.ncbi.nlm.nih.gov/pubmed/31736454
http://dx.doi.org/10.1017/S0950268819001857
_version_ 1783472616295628800
author Doan, T. N.
Varleva, T.
Zamfirova, M.
Tyufekchieva, M.
Keshelava, A.
Hristov, K.
Yaneva, A.
Gadzheva, B.
Zhang, S.
Irbe, S.
Ragonnet, R.
McBryde, E. S.
Trauer, J. M.
author_facet Doan, T. N.
Varleva, T.
Zamfirova, M.
Tyufekchieva, M.
Keshelava, A.
Hristov, K.
Yaneva, A.
Gadzheva, B.
Zhang, S.
Irbe, S.
Ragonnet, R.
McBryde, E. S.
Trauer, J. M.
author_sort Doan, T. N.
collection PubMed
description As Bulgaria transitions away from Global Fund grant, robust estimates of the comparative impact of the various response strategies under consideration are needed to ensure sustained effectiveness of the tuberculosis (TB) programme. We tailored an established mathematical model for TB control to the epidemic in Bulgaria to project the likely outcomes of seven intervention scenarios. Under existing programmatic conditions projected forward, the country's targets for achieving TB elimination in the coming decades will not be achieved. No interventions under consideration were predicted to accelerate the baseline projected reduction in epidemiological indicators significantly. Discontinuation of the ‘Open Doors’ program and activities of non-governmental organisations would result in a marked exacerbation of the epidemic (increasing incidence in 2035 by 6–8% relative to baseline conditions projected forward). Changing to a short course regimen for multidrug-resistant TB (MDR-TB) would substantially decrease MDR-TB mortality (by 21.6% in 2035 relative to baseline conditions projected forward). Changing to ambulatory care for eligible patients would not affect TB burden but would be markedly cost-saving. In conclusion, Bulgaria faces important challenges in transitioning to a primarily domestically-financed TB programme. The country should consider maintaining currently effective programs and shifting towards ambulatory care to ensure program sustainability.
format Online
Article
Text
id pubmed-6873158
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-68731582019-12-04 Strategic investment in tuberculosis control in the Republic of Bulgaria Doan, T. N. Varleva, T. Zamfirova, M. Tyufekchieva, M. Keshelava, A. Hristov, K. Yaneva, A. Gadzheva, B. Zhang, S. Irbe, S. Ragonnet, R. McBryde, E. S. Trauer, J. M. Epidemiol Infect Original Paper As Bulgaria transitions away from Global Fund grant, robust estimates of the comparative impact of the various response strategies under consideration are needed to ensure sustained effectiveness of the tuberculosis (TB) programme. We tailored an established mathematical model for TB control to the epidemic in Bulgaria to project the likely outcomes of seven intervention scenarios. Under existing programmatic conditions projected forward, the country's targets for achieving TB elimination in the coming decades will not be achieved. No interventions under consideration were predicted to accelerate the baseline projected reduction in epidemiological indicators significantly. Discontinuation of the ‘Open Doors’ program and activities of non-governmental organisations would result in a marked exacerbation of the epidemic (increasing incidence in 2035 by 6–8% relative to baseline conditions projected forward). Changing to a short course regimen for multidrug-resistant TB (MDR-TB) would substantially decrease MDR-TB mortality (by 21.6% in 2035 relative to baseline conditions projected forward). Changing to ambulatory care for eligible patients would not affect TB burden but would be markedly cost-saving. In conclusion, Bulgaria faces important challenges in transitioning to a primarily domestically-financed TB programme. The country should consider maintaining currently effective programs and shifting towards ambulatory care to ensure program sustainability. Cambridge University Press 2019-11-18 /pmc/articles/PMC6873158/ /pubmed/31736454 http://dx.doi.org/10.1017/S0950268819001857 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Doan, T. N.
Varleva, T.
Zamfirova, M.
Tyufekchieva, M.
Keshelava, A.
Hristov, K.
Yaneva, A.
Gadzheva, B.
Zhang, S.
Irbe, S.
Ragonnet, R.
McBryde, E. S.
Trauer, J. M.
Strategic investment in tuberculosis control in the Republic of Bulgaria
title Strategic investment in tuberculosis control in the Republic of Bulgaria
title_full Strategic investment in tuberculosis control in the Republic of Bulgaria
title_fullStr Strategic investment in tuberculosis control in the Republic of Bulgaria
title_full_unstemmed Strategic investment in tuberculosis control in the Republic of Bulgaria
title_short Strategic investment in tuberculosis control in the Republic of Bulgaria
title_sort strategic investment in tuberculosis control in the republic of bulgaria
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873158/
https://www.ncbi.nlm.nih.gov/pubmed/31736454
http://dx.doi.org/10.1017/S0950268819001857
work_keys_str_mv AT doantn strategicinvestmentintuberculosiscontrolintherepublicofbulgaria
AT varlevat strategicinvestmentintuberculosiscontrolintherepublicofbulgaria
AT zamfirovam strategicinvestmentintuberculosiscontrolintherepublicofbulgaria
AT tyufekchievam strategicinvestmentintuberculosiscontrolintherepublicofbulgaria
AT keshelavaa strategicinvestmentintuberculosiscontrolintherepublicofbulgaria
AT hristovk strategicinvestmentintuberculosiscontrolintherepublicofbulgaria
AT yanevaa strategicinvestmentintuberculosiscontrolintherepublicofbulgaria
AT gadzhevab strategicinvestmentintuberculosiscontrolintherepublicofbulgaria
AT zhangs strategicinvestmentintuberculosiscontrolintherepublicofbulgaria
AT irbes strategicinvestmentintuberculosiscontrolintherepublicofbulgaria
AT ragonnetr strategicinvestmentintuberculosiscontrolintherepublicofbulgaria
AT mcbrydees strategicinvestmentintuberculosiscontrolintherepublicofbulgaria
AT trauerjm strategicinvestmentintuberculosiscontrolintherepublicofbulgaria